![Christopher Barry Wood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Barry Wood
Founder at
MedAnnex Ltd.
Profile
Christopher Barry Wood was the founder of Bioenvision, Inc. (1999), holding the title of Chief Executive Officer & Director; Medeva Plc (1986), holding the title of Chairman; NuCana Plc (1997), holding the title of Chairman & Chief Medical Officer; Genethics Ltd. (1989), holding the title of Director; MedAnnex Ltd. (2009), holding the title of Executive Chairman; and Thirty Holdings Ltd. (2018), holding the title of Chairman.
Current jobs include Chairman at EdixoMed Ltd., Chairman at Oncobiopharm Ltd., Director at MiNA Therapeutics Ltd., and Director at Mina (Holdings) Ltd. Former jobs include Chairman & Chief Executive Officer at Eurobiotech, Inc. (1995-1999), Executive Chairman at Navion Ltd., Director at Osteologix, Inc., Director at Osteologix Holdings Plc, and Senior Medical Adviser at Deepbridge Capital LLP.
Education includes a doctorate from Cardiff University School of Medicine.
Christopher Barry Wood active positions
| Companies | Position | Start |
|---|---|---|
EdixoMed Ltd.
 EdixoMed Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Chairman | - |
MedAnnex Ltd.
 MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology approaches for treating autoimmune diseases | Founder | 2008-12-31 |
Oncobiopharm Ltd. | Chairman | - |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology Develops biological and medical products | Director/Board Member | - |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 2014-12-16 |
Thirty Holdings Ltd.
 Thirty Holdings Ltd. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiary develops anti-infective nitric oxide technology platform for healthcare sector | Founder | 2017-12-31 |
Former positions of Christopher Barry Wood
| Companies | Position | End |
|---|---|---|
| NUCANA PLC | Founder | 2020-06-24 |
Navion Ltd.
 Navion Ltd. Pharmaceuticals: MajorHealth Technology Focuses on discoveries in the areas of cancer and metastatic disease | Chairman | 2014-01-06 |
| OSTEOLOGIX HOLDINGS PLC | Director/Board Member | 2009-12-28 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Christopher Barry Wood
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Provides research and development services on pharmaceutical products | Health Services |
Osteologix, Inc. /Old/
 Osteologix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Medeva Plc
 Medeva Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company for the development, manufacture and sale of pharmaceutical products | Health Technology |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Operates as an investment holding company with interest in development of pharmaceuticals | Health Technology |
Eurobiotech, Inc. | |
Navion Ltd.
Navion Ltd. Pharmaceuticals: MajorHealth Technology Focuses on discoveries in the areas of cancer and metastatic disease | Health Technology |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Cardiff University School of Medicine
 Cardiff University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology Develops biological and medical products | Health Technology |
Genethics Ltd. | |
Deepbridge Capital LLP
 Deepbridge Capital LLP Investment ManagersFinance Deepbridge invests in companies located in the United Kingdom. The firm focuses on sectors such as technology, life sciences and renewable energy. It participates in seed, early and growth stage transactions. | Finance |
EdixoMed Ltd.
EdixoMed Ltd. BiotechnologyHealth Technology Engages in research and development of biotechnology | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops biotechnology approaches for treating autoimmune diseases | Commercial Services |
Oncobiopharm Ltd. | |
Thirty Holdings Ltd.
Thirty Holdings Ltd. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiary develops anti-infective nitric oxide technology platform for healthcare sector | Technology Services |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
- Stock Market
- Insiders
- Christopher Barry Wood
